Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-04-28Clinical Trial Update: Comparison of TACE Versus TACE/TACI Combination in Advanced Hepatocellular Carcinoma With Portal Vein Invasion [NA]
The clinical trial comparing TACE alone to TACE with TACI in advanced hepatocellular carcinoma with portal vein invasion has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-04-27Clinical Trial Update: The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma [Phase 2]
The Phase 2 trial evaluating 5-fluorouracil/Mitomycin for hepatocellular carcinoma with pulmonary metastasis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-04-27Clinical Trial Update: A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular Carcinoma [Phase 3]
A Phase 3 trial comparing transarterial chemoembolization (TACE) and transarterial radioembolization (TARE) for unilobar advanced hepatocell…
-
CLINICAL_TRIALS withdrawal · 2016-04-26Clinical Trial Update: Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent [NA]
A clinical trial comparing unilateral versus bilateral stenting for malignant hilar biliary obstruction using an LCD stent has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2015-12-24Clinical Trial Update: SBRT + TACE for Primary Hepatocellular Carcinoma [NA]
This clinical trial update indicates that the study evaluating the combination of SBRT and TACE for hepatocellular carcinoma has been withdr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-11-26Clinical Trial Update: Chemoembolization With or Without Stereotactic Body Radiosurgery for Liver Cancer [NA]
The clinical trial NCT02304445 evaluating chemoembolization with or without stereotactic body radiotherapy for hepatocellular carcinoma has …
-
CLINICAL_TRIALS withdrawal · 2015-09-23Clinical Trial Update: 24hr Imaging Of HCC After EOVIST [EARLY_Phase 1]
This is a withdrawal notice for an early-phase trial evaluating 24-hour imaging of hepatocellular carcinoma after EOVIST.
-
CLINICAL_TRIALS withdrawal · 2015-06-09Clinical Trial Update: Response of Hepatic Tumors to Radioembolization [Phase 2]
Phase 2 trial evaluating hepatic tumors (hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and liver metastases) after radioemboliz…
-
CLINICAL_TRIALS withdrawal · 2015-04-16Clinical Trial Update: AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
Clinical trial evaluating AZD6244 (selumetinib) and sorafenib in advanced hepatocellular carcinoma was terminated (Phase 1/Phase 2) accordin…
-
CLINICAL_TRIALS withdrawal · 2015-04-16Clinical Trial Update: A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC) [Phase 1]
Phase Ib trial of stereotactic body radiotherapy plus sorafenib for unresectable hepatocellular carcinoma has been withdrawn. The study stat…
-
CLINICAL_TRIALS withdrawal · 2014-12-11Clinical Trial Update: Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors [NA]
This clinical trial update indicates that Vanderbilt University’s study on early enteral tube feedings for children undergoing chemotherapy …
-
CLINICAL_TRIALS withdrawal · 2014-12-02Clinical Trial Update: TACE With or Without Radiation Therapy in Treating Patients With Stage A-C Liver Cancer [Phase 2]
A Phase 2 trial evaluating transarterial chemoembolization (TACE) with or without radiation therapy for stage I–III hepatocellular carcinoma…
-
CLINICAL_TRIALS withdrawal · 2014-10-22Clinical Trial Update: Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC) [Phase 2]
A Phase 2 study evaluating sorafenib with gemcitabine and cisplatin for advanced hepatocellular carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-07-22Clinical Trial Update: Associating Liver Partition With Portal Vein Ligation For Staged Hepatectomy (ALPPS) or Portal Vein Occlusion in Treating Patients With Liver Cancer [Phase 2]
The Phase 2 clinical trial evaluating ALPPS or portal vein occlusion for hepatocellular carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-07-16Clinical Trial Update: Radiofrequency Ablation in Treating Patients With Liver Cancer (Hepatocellular Carcinoma) [Phase 2]
The Phase 2 trial evaluating radiofrequency ablation for hepatocellular carcinoma (liver cancer) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-06-26Clinical Trial Update: Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC) [Phase 2]
Phase 2 trial evaluating radiation therapy in combination with transarterial chemoembolization for hepatocellular carcinoma has been withdra…
-
CLINICAL_TRIALS withdrawal · 2014-05-19Clinical Trial Update: Prospective, Observational Study of Biomarkers in Liver Cancer - Identification of Actionable Events
A prospective observational study of biomarkers in liver cancer (hepatocellular carcinoma) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-05-16Clinical Trial Update: Treatment of Non-Metastatic Hepatocellular Carcinoma in Humans by Increasing Gabaergic Activity: A Pilot Study [Phase 2]
A Phase 2 pilot trial investigating increased GABAergic activity for hepatocellular carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-01-28Clinical Trial Update: Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver
A clinical trial evaluating gadoxetic acid-enhanced MRI for hepatocellular carcinoma and dysplastic nodules in cirrhotic liver has been with…
-
CLINICAL_TRIALS withdrawal · 2013-09-05Clinical Trial Update: Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma [Phase 1]
Phase 1 trial evaluating radiation therapy with sorafenib for hepatocellular carcinoma resistant to transarterial chemoembolization has been…
-
CLINICAL_TRIALS withdrawal · 2013-07-04Clinical Trial Update: Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer [Phase 2]
A Phase 2 trial evaluating pegylated liposomal doxorubicin and temsirolimus for advanced hepatocellular carcinoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-05-30Clinical Trial Update: Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer [Phase 3]
A Phase 3 trial evaluating surgery with or without hepatic arterial chemotherapy for liver cancer in adults and children has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-01-23Clinical Trial Update: Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed [Phase 2]
A phase 2 trial of erlotinib for unresectable hepatocellular carcinoma was terminated.
-
CLINICAL_TRIALS withdrawal · 2012-10-04Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial of a vaccine therapy for liver cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-08-23Clinical Trial Update: The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma [NA]
This entry announces the withdrawal of a clinical trial evaluating postoperative interferon-alpha treatment in p48-positive hepatocellular c…